Intranasal COVID-19 vaccine candidate shows sterilizing immunity in preclinical tests

University of Alabama at Birmingham researchers report additional preclinical evidence of the potency of a single-dose, intranasal COVID-19 vaccine candidate—AdCOVID—that was created by Altimmune Inc., a Maryland-based clinical-stage biopharmaceutical company. The UAB researchers, led by Fran Lund, Ph.D., in collaboration with Altimmune, have found that a single intranasal dose provided […]

The Future of Pandemics

In December 2019, a novel coronavirus (SARS-CoV-2 ) was identified in Wuhan, China. By the 11th of March of 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. A year later, more than 2.5 million deaths worldwide have been attributed to infection of the new viral strain […]

J&J Vaccine Reviewed for Links to More Reports of Side Effects

(Reuters) – The United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson’s COVID-19 vaccine in addition to those that led to a pause in its use, a top U.S. public health official said on Monday. U.S. health […]

Denmark won't use AstraZeneca COVID-19 vaccine following reports of rare blood clots

AstraZeneca US chief lauds new vaccine, dismisses blood clot concerns AZ US President Ruud Dobber tells ‘Your World’ studies showed no significant clotting side effects BARCELONA, Spain – European countries diverged Wednesday on whether they would push ahead with giving their residents Johnson & Johnson’s COVID-19 vaccine after reports of […]

France Opts for mRNA Vaccines for Second Coronavirus Shot

PARIS (Reuters) – France’s top health advisory body in charge of COVID-19 vaccines recommended on Friday that recipients of a first dose of the AstraZeneca shot who are under 55 should receive a second dose with a so-called messenger RNA vaccine. Reuters reported on Thursday that the Haute Autorite de […]